OGT, using their specialised expertise in the development of superior hybridisation-based capture technology, ensures that ...

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...